human myeloid progenitor cells

BIOLOGICAL2 trials

Sponsors

Cellerant Therapeutics

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid LeukemiaLeukemiaLymphomaMultiple MyelomaMyelodysplasiaMyelodysplastic Syndromes

Phase 1

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

CompletedNCT00891137

Cellerant TherapeuticsLeukemia, Lymphoma, Multiple Myeloma +2

Start: 2009-04-30End: 2014-06-30Updated: 2014-10-27

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

CompletedNCT01297543

Cellerant TherapeuticsAcute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia +1

Start: 2011-03-31End: 2015-01-31Updated: 2016-07-01